retatrutide phase 2 trial obesity triple agonist First-in-Class 'Triple-G'! Retatrutide, a first-in Eli Lilly infiltrates anti-obesity market
Pay in 4 interest-free payments of $7.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


01053-X/asset/68ad1d8b-bb7e-4ca0-8f89-99384d885ca3/main.assets/gr2.jpg)


























